DK2090318T3 - Profylaktisk tuberkulosevaccine - Google Patents

Profylaktisk tuberkulosevaccine

Info

Publication number
DK2090318T3
DK2090318T3 DK07822990.3T DK07822990T DK2090318T3 DK 2090318 T3 DK2090318 T3 DK 2090318T3 DK 07822990 T DK07822990 T DK 07822990T DK 2090318 T3 DK2090318 T3 DK 2090318T3
Authority
DK
Denmark
Prior art keywords
tuberculosis vaccine
prophylactic
prophylactic tuberculosis
vaccine
tuberculosis
Prior art date
Application number
DK07822990.3T
Other languages
English (en)
Inventor
Iglesias Pere Joan Cardona
Riera Isabel Amat
Original Assignee
Archivel Farma Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Archivel Farma Sl filed Critical Archivel Farma Sl
Application granted granted Critical
Publication of DK2090318T3 publication Critical patent/DK2090318T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/04Mycobacterium, e.g. Mycobacterium tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55555Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK07822990.3T 2006-10-30 2007-10-17 Profylaktisk tuberkulosevaccine DK2090318T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200602754A ES2307402B1 (es) 2006-10-30 2006-10-30 Vacuna profilactica contra la tuberculosis.
PCT/ES2007/000583 WO2008053055A1 (es) 2006-10-30 2007-10-17 Vacuna profiláctica contra la tuberculosis

Publications (1)

Publication Number Publication Date
DK2090318T3 true DK2090318T3 (da) 2012-11-19

Family

ID=39343853

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07822990.3T DK2090318T3 (da) 2006-10-30 2007-10-17 Profylaktisk tuberkulosevaccine

Country Status (20)

Country Link
US (1) US9289483B2 (da)
EP (1) EP2090318B1 (da)
JP (1) JP2010508254A (da)
KR (1) KR20090087874A (da)
CN (1) CN101600455B (da)
AU (1) AU2007316091B2 (da)
BR (1) BRPI0715297B8 (da)
CA (1) CA2667965C (da)
DK (1) DK2090318T3 (da)
ES (2) ES2307402B1 (da)
HK (1) HK1138786A1 (da)
IL (1) IL198357A (da)
MX (1) MX2009004258A (da)
NZ (1) NZ576489A (da)
PL (1) PL2090318T3 (da)
PT (1) PT2090318E (da)
RU (1) RU2526910C2 (da)
UA (1) UA104126C2 (da)
WO (1) WO2008053055A1 (da)
ZA (1) ZA200902937B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2335177B1 (es) * 2008-09-19 2011-02-28 Archivel Farma, S.L. Agente inmunoterapeutico apropiado para la profilaxis primaria de la tuberculosis.
CN104744476B (zh) 2008-12-08 2017-04-12 吉利德康涅狄格公司 咪唑并吡嗪syk抑制剂
JP5696052B2 (ja) 2008-12-08 2015-04-08 ギリアード コネチカット, インコーポレイテッド イミダゾピラジンsyk阻害剤
EP2471511A1 (en) 2011-01-04 2012-07-04 Archivel Farma, SL Liposome formulation suitable for treating or preventing tuberculosis
BR112013017267B1 (pt) 2011-01-04 2021-06-22 Archivel Farma, Sl Formulação de lipossomas, suspensão e composição farmacêutica
DK2802345T3 (da) * 2012-01-12 2018-04-30 Archivel Farma Sl Mtb-c-vaccine mod allergiske reaktioner
KR20210131372A (ko) 2019-02-22 2021-11-02 크로노스 바이오, 인코포레이티드 Syk 억제제로서의 축합된 피라진의 고체 형태
WO2023062066A1 (en) 2021-10-14 2023-04-20 Archivel Farma, S.L. Liposome formulations for treatment of active tuberculosis

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6641814B1 (en) * 1997-04-02 2003-11-04 Statens Serum Institut Nucleic acids fragments and polypeptide fragments derived from M. tuberculosis
RU2093046C1 (ru) * 1996-05-06 1997-10-20 Тихоокеанский институт биоорганической химии Дальневосточного отделения РАН Лечебно-профилактическая пищевая композиция "гербамарин"
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
AP9901670A0 (en) * 1997-03-03 1999-12-31 Adcock Ingram Ltd A composition comprising a carrier and a purified mycobacterial lipid cell-wall component and its use in the prevention, treatment and diagnosis of disease.
US7037510B2 (en) * 1997-04-18 2006-05-02 Statens Serum Institut Hybrids of M. tuberculosis antigens
EP1117683A2 (en) 1998-10-08 2001-07-25 Statens Serum Institut Tb vaccine and diagnostic based on antigens from the m. tuberculosis cell
RU2153354C1 (ru) * 1999-03-31 2000-07-27 Московский городской научно-практический центр борьбы с туберкулезом Вакцина против туберкулеза
US6420342B1 (en) * 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
WO2002045736A1 (en) * 2000-12-08 2002-06-13 The Johns Hopkins University Methods for improved diagnosis and treatment of mycobacterial infections
EP2196473A1 (en) 2001-07-04 2010-06-16 Health Protection Agency Mycobacterial antigens expressed during latency
ZA200400843B (en) * 2001-08-02 2007-11-28 Univ New York Early detection of mycobacterial disease using peptides
WO2003018053A1 (en) 2001-08-22 2003-03-06 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Vaccine against mycobacterial-induced diseases
BR0307262A (pt) * 2002-01-29 2006-12-19 Bakulesh Mafatlal Khamar método de prover profilaxia para tuberculose em indivìduos hiv positivos
CN1467221A (zh) * 2002-07-14 2004-01-14 虹 王 结核杆菌cfp-10、esat-6与cd40l融合疫苗的制备及应用
ES2231037B1 (es) * 2003-10-31 2005-12-16 Archivel Technologies, Sl Agente inmunoterapico util para el tratamiento combinado de la tuberculosis en asociacion con otros farmacos.
ES2335177B1 (es) * 2008-09-19 2011-02-28 Archivel Farma, S.L. Agente inmunoterapeutico apropiado para la profilaxis primaria de la tuberculosis.

Also Published As

Publication number Publication date
IL198357A0 (en) 2011-08-01
HK1138786A1 (en) 2010-09-03
ES2393007T3 (es) 2012-12-17
CN101600455B (zh) 2013-08-07
MX2009004258A (es) 2009-05-11
US9289483B2 (en) 2016-03-22
IL198357A (en) 2013-03-24
KR20090087874A (ko) 2009-08-18
CA2667965C (en) 2016-08-23
BRPI0715297B8 (pt) 2021-05-25
JP2010508254A (ja) 2010-03-18
EP2090318A1 (en) 2009-08-19
ES2307402B1 (es) 2009-09-30
EP2090318B1 (en) 2012-08-08
RU2009120522A (ru) 2013-01-20
AU2007316091B2 (en) 2013-06-27
PT2090318E (pt) 2012-11-14
AU2007316091A1 (en) 2008-05-08
BRPI0715297B1 (pt) 2019-01-29
RU2526910C2 (ru) 2014-08-27
US20100068258A1 (en) 2010-03-18
NZ576489A (en) 2012-02-24
EP2090318A4 (en) 2010-01-27
PL2090318T3 (pl) 2013-03-29
ZA200902937B (en) 2010-02-24
WO2008053055A1 (es) 2008-05-08
ES2307402A1 (es) 2008-11-16
BRPI0715297A2 (pt) 2015-02-03
CA2667965A1 (en) 2008-08-05
UA104126C2 (ru) 2014-01-10
CN101600455A (zh) 2009-12-09

Similar Documents

Publication Publication Date Title
NO2021010I1 (no) telostritat ethyl
ATE450271T1 (de) Impfstoff
DK1968631T3 (da) Vaccine
CR10571A (es) Vacuna virica recombinante
DK2114993T3 (da) Vaccine
FI20065288A0 (fi) Autentikointi
BRPI0909770A2 (pt) Vacina, e, kit
DK2069503T3 (da) Papayamosaikvirus-baserede vacciner mod influenza
DK2422810T3 (da) Influenzavaccine
AT504580A3 (de) Scan-einrichtung
ATE546437T1 (de) Aminomethyl-4-imidazole
DE502007000218D1 (de) nsetzungen
DE502007000361D1 (de) Stanznieteinheit
DK2090318T3 (da) Profylaktisk tuberkulosevaccine
DE102006045567A8 (de) Crimpstabilisierung
DE112007003147A5 (de) Rohr-Biegevorrichtung
BRPI0719956A2 (pt) Radiofluoração
ATE513657T1 (de) Nagelvorrichtung
FI20065534A0 (fi) Synkronisointi
EP1997881A4 (en) TUBERCULOSIS VACCINE
DE112007001125A5 (de) Käfigmutter
DE502007001094D1 (de) Hubkupplung
DE112006003389A5 (de) Geteiltes schwungrad
SE0600253L (sv) Hållaranordning
AT504095A3 (de) Halteeinrichtung